Cubist Systematic Strategies’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-51,161
| Closed | -$238K | – | 2411 |
|
|
2024
Q1 | $238K | Buy |
+51,161
| New | +$238K | ﹤0.01% | 1616 |
|
|
2023
Q3 | – | Sell |
-15,477
| Closed | -$38.1K | – | 2485 |
|
|
2023
Q2 | $38.1K | Sell |
15,477
-22,024
| -59% | -$54.2K | ﹤0.01% | 1934 |
|
|
2023
Q1 | $84.8K | Sell |
37,501
-3,189
| -8% | -$7.21K | ﹤0.01% | 2438 |
|
|
2022
Q4 | $142K | Buy |
40,690
+5,565
| +16% | +$19.4K | ﹤0.01% | 2766 |
|
|
2022
Q3 | $1.3M | Sell |
35,125
-6,192
| -15% | -$229K | 0.01% | 1883 |
|
|
2022
Q2 | $785K | Buy |
41,317
+7,586
| +22% | +$144K | ﹤0.01% | 2280 |
|
|
2022
Q1 | $910K | Buy |
33,731
+32,822
| +3,611% | +$885K | 0.01% | 2100 |
|
|
2021
Q4 | $20K | Sell |
909
-13,151
| -94% | -$289K | ﹤0.01% | 3377 |
|
|
2021
Q3 | $369K | Buy |
14,060
+12,841
| +1,053% | +$337K | ﹤0.01% | 2227 |
|
|
2021
Q2 | $39K | Buy |
1,219
+1,190
| +4,103% | +$38.1K | ﹤0.01% | 2813 |
|
|
2021
Q1 | $1K | Sell |
29
-595
| -95% | -$20.5K | ﹤0.01% | 2800 |
|
|
2020
Q4 | $20K | Sell |
624
-314
| -33% | -$10.1K | ﹤0.01% | 2501 |
|
|
2020
Q3 | $35K | Buy |
+938
| New | +$35K | ﹤0.01% | 2386 |
|